Generics BulletinKey personnel moves are afoot at both Stada and Medicines for Europe, after Stephan Eder stepped down from his current roles as executive vice-president for Western Europe and Germany at Stada and pre
Generics BulletinStada has credited its Alvotech-partnered Uzpruvo (ustekinumab) European biosimilar rival to Stelara for driving up its sales in the first quarter of 2025. The German giant’s Specialty division – whic
Generics BulletinIf Stada is indeed set to announce an initial public offering in the coming days, then its latest results have been positioned as a strong enticement to invest in the firm, which says it is outperform
Generics BulletinEuropean off-patent industry association Medicines for Europe has named Stada’s head of western Europe and Germany, Stephan Eder, to become the industry body’s new president for a two-year term. Eder